Leopoldo Luistro

2.7k total citations · 1 hit paper
28 papers, 2.2k citations indexed

About

Leopoldo Luistro is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Leopoldo Luistro has authored 28 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Leopoldo Luistro's work include Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immune Cell Function and Interaction (8 papers). Leopoldo Luistro is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immune Cell Function and Interaction (8 papers). Leopoldo Luistro collaborates with scholars based in United States, Switzerland and Belgium. Leopoldo Luistro's co-authors include Michael J. Brunda, Maurice K. Gately, Rosemary Wright, Rajeev R. Warrier, Brian Hubbard, Maureen E. Murphy, S F Wolf, Kathryn Packman, Jill A. Hendrzak and Melissa Smith and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Cancer Research.

In The Last Decade

Leopoldo Luistro

27 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

1993 1.0k citations Michael J. Brunda, Leopoldo Luistro et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leopoldo Luistro United States	15	1.1k	1.0k	777	305	281	28	2.2k
Gundram Jung Germany	31	1.7k 1.5×	1.4k 1.4×	871 1.1×	149 0.5×	729 2.6×	114	2.9k
Jon M. Wigginton United States	32	2.0k 1.8×	2.1k 2.0×	823 1.1×	248 0.8×	203 0.7×	100	3.5k
Danita H. Schuurhuis Netherlands	26	1.9k 1.7×	928 0.9×	888 1.1×	168 0.6×	405 1.4×	36	2.8k
Robin Parihar United States	22	1.5k 1.3×	1.4k 1.3×	482 0.6×	197 0.6×	342 1.2×	47	2.3k
Cory L. Ahonen United States	16	2.1k 1.9×	1.0k 1.0×	542 0.7×	136 0.4×	226 0.8×	19	3.0k
Fernando Aranda Spain	28	1.5k 1.3×	1.3k 1.3×	644 0.8×	240 0.8×	116 0.4×	76	2.5k
Diletta Laccabue Italy	22	1.2k 1.0×	1.0k 1.0×	620 0.8×	110 0.4×	509 1.8×	35	3.1k
Paul Simon United States	11	1.9k 1.7×	1.4k 1.3×	704 0.9×	442 1.4×	442 1.6×	23	3.1k
Sam T. Hwang United States	24	1.7k 1.5×	1.5k 1.4×	1.2k 1.5×	197 0.6×	81 0.3×	43	3.2k
Hung T. Khong United States	25	1.7k 1.5×	1.9k 1.9×	980 1.3×	444 1.5×	112 0.4×	71	3.0k

Countries citing papers authored by Leopoldo Luistro

Since Specialization

Citations

This map shows the geographic impact of Leopoldo Luistro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leopoldo Luistro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leopoldo Luistro more than expected).

Fields of papers citing papers by Leopoldo Luistro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leopoldo Luistro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leopoldo Luistro. The network helps show where Leopoldo Luistro may publish in the future.

Co-authorship network of co-authors of Leopoldo Luistro

This figure shows the co-authorship network connecting the top 25 collaborators of Leopoldo Luistro. A scholar is included among the top collaborators of Leopoldo Luistro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leopoldo Luistro. Leopoldo Luistro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pillarisetti, Kodandaram, Danlin Yang, Leopoldo Luistro, et al.. (2025). Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models. Blood. 147(8). 834–847. 3 indexed citations

Yang, Danlin, Jianhong Yao, Melissa Smith, et al.. (2023). Characterization of JNJ-79635322, a Novel BCMAxGPRC5DxCD3 T-Cell Redirecting Trispecific Antibody, for the Treatment of Multiple Myeloma. Blood. 142(Supplement 1). 456–456. 19 indexed citations

Zwolak, Adam, Szeman Ruby Chan, Anthony A. Armstrong, et al.. (2022). A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3. Scientific Reports. 12(1). 20538–20538. 5 indexed citations

Rudnick, Stephen I., Leopoldo Luistro, Melissa Smith, et al.. (2020). Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironment. Blood Cancer Journal. 10(6). 65–65. 23 indexed citations

Villarreal, Daniel O., Diana Chin, Melissa Smith, Leopoldo Luistro, & Linda A. Snyder. (2017). Combination GITR targeting/PD-1 blockade with vaccination drives robust antigen-specific antitumor immunity. Oncotarget. 8(24). 39117–39130. 16 indexed citations

Izhak, Liat, Dana E. Cullen, Leopoldo Luistro, et al.. (2017). Abstract 3636: Potent antitumor activity of duvortuxizumab, a CD19 x CD3 DART® molecule, in lymphoma models. Cancer Research. 77(13_Supplement). 3636–3636. 7 indexed citations

Luistro, Leopoldo, Diana Chin, Melissa Smith, et al.. (2017). Abstract 1101: Telomerase inhibitor imetelstat in combination with the BCL-2 inhibitor venetoclax enhances apoptosis in vitro and increases survival in vivo in acute myeloid leukemia. Cancer Research. 77(13_Supplement). 1101–1101. 4 indexed citations

Moores, Sheri L., Mark L. Chiu, Barbara S. Bushey, et al.. (2016). A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor–Resistant Lung Tumors. Cancer Research. 76(13). 3942–3953. 188 indexed citations

Pillarisetti, Kodandaram, Eric T. Baldwin, Alexander Babich, et al.. (2016). Development of a New BCMAxCD3 Duobody® Antibody for Multiple Myeloma. Blood. 128(22). 2116–2116. 8 indexed citations

10.

Rudnick, Stephen I., Leopoldo Luistro, Diana Chin, et al.. (2016). The Impact of the Bone Marrow Microenvironment on T Cell Redirection Therapeutics. Blood. 128(22). 2752–2752. 1 indexed citations

11.

Luistro, Leopoldo, James Rosinski, Hongjin Bian, et al.. (2012). Development and characterization of a preclinical ovarian carcinoma model to investigate the mechanism of acquired resistance to trastuzumab. International Journal of Oncology. 41(2). 639–651. 7 indexed citations

12.

Herold, Andrea, Tobias Bergauer, Anton Belousov, et al.. (2012). Gene expression analysis in biomarker research and early drug development using function tested reverse transcription quantitative real-time PCR assays. Methods. 59(1). 10–19. 14 indexed citations

13.

He, Wei, Leopoldo Luistro, Daisy Carvajal, et al.. (2011). High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ‐secretase inhibitor, RO4929097. Molecular Oncology. 5(3). 292–301. 38 indexed citations

14.

Luistro, Leopoldo, Wei He, Melissa Smith, et al.. (2009). Preclinical Profile of a Potent γ-Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties. Cancer Research. 69(19). 7672–7680. 154 indexed citations

15.

Luistro, Leopoldo, James Rosinski, Hongjin Bian, Nicholas M. Ponzio, & S Ritland. (2005). Herceptin-refractory ovarian carcinoma cells differentially express genes involved in angiogenesis, invasion, and metastasis. Cancer Research. 65. 1201–1201. 1 indexed citations

16.

Luistro, Leopoldo, Christian Tovar, Subal Bishayee, et al.. (2004). Development and characterization of a pre-clinical model of ovarian carcinoma to investigate mechanisms of resistance to the anti-HER2/neu antibody Herceptin™. Cancer Research. 64. 276–276. 1 indexed citations

17.

Brunda, Michael J., Leopoldo Luistro, Rosemary Wright, et al.. (1996). Interleukin‐12: Murine Models of a Potent Antitumor Agenta. Annals of the New York Academy of Sciences. 795(1). 266–274. 23 indexed citations

18.

Brunda, Michael J., Leopoldo Luistro, Jill A. Hendrzak, et al.. (1995). Role of Interferon-γ in Mediating the Antitumor Efficacy of Interleukin-12. Journal of Immunotherapy. 17(2). 71–77. 146 indexed citations

19.

Brunda, Michael J., et al.. (1994). Enhanced Antitumor Efficacy in Mice by Combination Treatment with Interleukin-1α and Interferon-α. Journal of Immunotherapy. 15(4). 233–241. 6 indexed citations

20.

Brunda, Michael J., Leopoldo Luistro, Rajeev R. Warrier, et al.. (1993). Antitumor and antimetastatic activity of interleukin 12 against murine tumors.. The Journal of Experimental Medicine. 178(4). 1223–1230. 1031 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact